Rapt Therapeutics, Inc. (RAPT)
36.76
+1.44
(+4.08%)
USD |
NASDAQ |
Dec 10, 16:00
36.76
0.00 (0.00%)
After-Hours: 19:26
Rapt Therapeutics Total Liabilities (Quarterly): 13.76M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Replimune Group, Inc. | 126.11M |
| Olema Pharmaceuticals, Inc. | 44.96M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
| Theriva Biologics, Inc. | 24.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 165.74M |
| Shareholders Equity (Quarterly) | 151.98M |
| Debt to Equity Ratio | 0.0171 |
| Current Ratio | 12.04 |
| Net Debt Paydown Yield | 0.15% |